Objectives: Mitsugumin 53 (MG53) is a myokine that acts as a membrane repair protein in tissues. Data on the effect of MG53 on insulin signaling and type 2 diabetes mellitus (T2 DM) are still unknown; most are from preclinical studies. Nevertheless, some researchers have argued that it may be a new pathogenic factor, and therapies targeting MG53 may be a new avenue for T2 DM. Our study aims to evaluate the relationship of circulating MG53 levels with the presence of diabetes, diabetic complications, and glycemic control. Methods: We conducted a case-control study with 107 patients with T2 DM and 105 subjects without insulin resistance-related disease. Concurrent blood samples were used for serum MG53 levels and other biochemical laboratory data. MG53 concentration was measured using Human-MG53, an enzyme-linked immunosorbent assay kit (Cat# CSB-EL024511HU). Results: We found no difference in MG53 levels between the diabetic and control groups (p = 0.914). Furthermore, when the subjects were divided into tertiles according to their MG53 levels, we did not find any difference between the groups in terms of the presence of diabetes (p = 0.981). Additionally, no correlation was observed between weight, BMI, waist circumference, systolic and diastolic blood pressure, fasting blood glucose, HbA1c, albumin excretion in the urine, e-GFR levels, and MG53. Finally, MG53 levels were similar between the groups with and without microvascular and macrovascular complications of diabetes. Conclusion: Our research finding provides insightful clinical evidence of lack of association between the levels of MG53 and T2 DM or glycemic control, at least in the studied population of Turkeys ethnicity. However, further clinical studies are warranted to establish solid evidence of the link between MG53, insulin resistance and glycemic control in a wider population elsewhere in the world.
Climate change is recognized by the World Economic Forum as one of the top ten global crises. Existing scales measure awareness in adults, but there is no scale specifically developed for early adolescents. To address this gap, the "Early Adolescent Climate Change Awareness Scale" (EACCAS) was developed. The study targeted individuals aged 10–14 in Edirne, Türkiye (N = 7133, 25 schools). A multi-stage stratified cluster sampling method was used to select (n=897, 6 schools). A 43-item pool was generated based on literature and educational materials, and content validity was evaluated by nine experts. Feedback from a pilot study involving 21 students was used to refine the items. Data collection proceeded after obtaining ethical approvals. Structural validity was assessed through Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) on two equal subsamples, while convergent and discriminant validity were tested. Reliability was measured using Cronbach's alpha coefficient. Analyses were conducted using SPSS 22 and R Studio’s “lavaan” and “semTools” packages. The final scale consisted of 15 items across three subdimensions—causes, consequences, and measures—explaining 65.53% of the total variance. The Cronbach's alpha value was 0.92, and model fit indices indicated a good fit (CMIN/DF = 2.176, RMSEA = 0.051, CFI = 0.968, TLI= 0.961, SRMR= 0.041). The scale, scored on a 5-point Likert system (1 = strongly disagree, 5 = strongly agree), provides a range of 15–75 points. Higher scores indicate greater awareness. This scale is recommended for application in diverse populations following cultural adaptations.
Background and Objectives: MG53 is a myokine/cardiokine involved in membrane repair. Some preclinical studies suggest that it is associated with insulin resistance. Metabolic syndrome (MS) is manifested by dyslipidemia, hypertension (HT), visceral obesity, hyperinsulinism, and glucose intolerance. We aimed to evaluate the relationship between the MG53 protein and MS and its components. Materials and Methods: This study was conducted among 64 patients with MS and 64 age- and sex-matched healthy participants. MG53 levels were measured using Human-MG53, a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Cat# CSB-EL024511HU, Alfagen laboratory supplies, Cusabio, Bornova, İzmir.). Results: There was no significant connection between serum MG53 levels and the presence of MS (p = 0.969). We found no correlation between serum MG53 levels and the presence of HT, weight, waist circumference, body mass index, HDL-C, fasting blood glucose, and HbA1c levels. Conclusions: This study’s results suggest no association between serum MG53 levels and MS parameters in the studied ethnic population. Due to the limited number and controversy of available studies on this subject, our findings may provide perspective for conducting studies with more diverse populations to obtain more comprehensive results.
ObjectiveRib fractures are common in thoracic trauma patients. There are various factors, including flail chest, pulmonary contusion, and accompanying conditions, affecting morbidity and mortality. The study aimed to identify high-risk patients for morbidity and mortality with a scoring system that the authors created.MethodsCases over the age of 18 admitted due to trauma and diagnosed with rib fractures between 1 January 2019 and 1 March 2023, were included. Trauma scores were determined by applying the new trauma scoring system. Trauma scores and other variables regarding morbidity and mortality were evaluated.ResultsA total of 1023 cases were included in the study. The total trauma scores were higher in bilateral and multiple fractures. In those without respiratory failure, the total score was statistically significantly lower than in the groups with respiratory failure. The total score was significantly higher in those who needed surgery, those who were hospitalized, and those who needed intensive care compared to the non-surgical groups. However, there was no correlation between intensive care unit stay and total score. Trauma mechanism, presence of additional extrathoracic pathology, and thoracic trauma-age score were independent predictors of survival.ConclusionThe present study demonstrated that the number of rib fractures and the presence of pulmonary contusion did not have an effect on mortality and morbidity. The presence of extrathoracic pathology and age significantly affect survival.
Amaç Safra taşları, toplum genelinde sık rastlanan gastrointestinal sorunların başında yer almaktadır. Güncel rehberlerde semptomatik safra taşlarının tedavisinde kolesistektomi önerilirken asemptomatik olgularda cerrahi önerilmemektedir. Bu çalışmada, klinik pratikte asemptomatik safra taşlarına yaklaşımda kolesistektomi sıklığı ve etki eden faktörlerin araştırılması amaçlanmıştır. Araçlar ve Yöntem Bu çalışma; prospektif, kesitsel nitelikte ve tanımlayıcı bir anket çalışması olarak tasarlanmıştır. Çalışmada kapsamında geçmişte safra taşı nedeni ile kolesistektomi uygulanan olgular değerlendirilmiştir. Yüz yüze görüşme yöntemi ile uygulanan ankette başlıca; cerrahi endikasyon, tıbbi bilgilendirme ve semptom değişimi yönünden bilgiler değerlendirilmiştir Bulgular Bu çalışmada kolesistektomi endikasyonları incelendiğinde; 75 (%35.4) olguda asemptomatik safra taşı olduğu ve profilaksi amaçlı opere edildiği; 62 (%29.2) olgu akut kolesistit, 6 (%2.8) olgu koledokolitiyazis, 1 (%0.5) olgu porselen kese, 3 (%1.4) olgu akut pankreatit, 2 (%0.9) olgu polip birlikteliği ve 63 (%29.7) olgunun ise semptomatik safra taşı nedeniyle opere edildiği belirlendi. Uygun olmayan endikasyonla cerrahi kararı verilmesinde; %64 ile genel cerrahi, %29.3 ile iç hastalıkları ve %4 ile gastroenteroloji bölümleri gözlendi. Sonuç Asemptomatik safra taşlarında endikasyon dışı cerrahi tedavi uygulanması günümüzde sık görülen bir durumdur. Bu nedenle konunun ilgili branşlar tarafından yeniden ele alınarak oluşabilecek tıbbi ve hukuki olumsuz durumların önlenebileceği değerlendirilmektedir.
30 December 2020 in Flora the Journal of Infectious Diseases and Clinical Microbiology